We sought to assess the relationship of serum resistin levels with PAH disease severity and survival in a large cohort of patients with PAH composed mainly of two subtypes: idiopathic PAH (IPAH) and scleroderma-associated PAH (SSc-PAH). The gene discussed is RETN; the disease is idiopathic pulmonary arterial hypertension.